Chinese AI, chip firms are driving an onshore IPO rebound

China’s onshore tech IPO market is on track for its strongest year since 2023, with $3.1 billion raised by June 18 and nearly 50 filings totaling at least 126.1 billion yuan ($18.7 billion). Regulators are explicitly supporting listings by chip, AI and other future-industry companies, while a 29.5 billion yuan CXMT IPO could be the year’s largest. The policy shift and strong IPO appetite should benefit domestic tech issuance, private equity exits and the broader AI/semiconductor ecosystem.

Analysis

The real winner here is not just the new issuers but the domestic capital-formation stack around them: banks running ECM, STAR Market gatekeepers, auditors, and local brokers with distribution into mainland retail. For the listed beneficiaries, the nearer-term alpha is in firms with China AI exposure and balance sheet optionality—BIDU is the cleanest liquid proxy because any success in domestic chip/AI financing improves ecosystem depth while reducing funding uncertainty for its chip initiatives and adjacent platform investments. GS and C benefit more modestly through cross-border ECM and financing volumes, but the bigger effect is reputational: a revived mainland tech IPO window can re-rate underwriting pipelines across Asia for 2H and into 2026.

Second-order, this is a competitive pressure event for Hong Kong capital markets. If mainland venues successfully re-open to tech and “future industries,” Hong Kong risks losing the premium on being the default fundraising bridge for China growth names; that should tighten valuation dispersion between HK-listed China tech and onshore peers. It also creates a private-market exit ladder that can pull venture funding back into frontier sectors, which is positive for early-stage supply but potentially negative for late-stage private valuations if sponsors rush to monetize into public liquidity before growth is fully proven.

The main risk is that this becomes a policy-driven rotation rather than a durable issuance cycle. If first-day pops are too extreme, regulators may slow approvals or demand more measured pricing, which would cool sentiment within weeks and punish the most levered pre-IPO investors first. Over a 6-12 month horizon, the key catalyst is whether large, credible names actually clear listing and trade well; if they do, the market could expand quickly, but if not, the current optimism will look like a short-lived liquidity trade rather than a secular reopening.

Key Decisions for Investors

• Long BIDU 3-6 months as a liquid China AI ecosystem proxy; thesis is that improved domestic IPO liquidity lowers funding risk for chip/AI adjacencies and supports a multiple re-rating. Use a tight risk budget because this is an indirect beneficiary, not a direct issuance winner.
• Long GS / long C basket against short regional China internet beta over 1-2 quarters; the trade captures incremental ECM/financing activity while reducing exposure to China consumer/ADR sentiment.
• Buy 6-12 month call spreads on BIDU rather than outright equity to express upside from a stronger domestic AI capital cycle with defined downside if approvals slow or policy tightens.
• Pair long Hong Kong exchange-linked exposure against short onshore broker/IPO hype names if valuations re-accelerate; the contrarian view is that the most obvious beneficiaries may have already priced in the reopening.
• Avoid chasing first-day IPO pops in mainland tech names; wait 2-4 weeks post-listing for supply to clear and for real institutional demand to reveal itself before adding exposure.